[Corrections] Corrections

Howard J F Jr, Utsugisawa K, Benatar M, et al. Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study. Lancet Neurol 2017; 16: 976 –86—In this Article, (published online Oct 20), the p value for one of the datapoints in figure 2 should be 0·0007. Additionally, in the sentence ‘Half of all patients reported their worst MGFA classification since diagnosis as class IV or V’ on page 6, the citation at the end of the senten ce should be ‘appendix’.
Source: Lancet Neurology - Category: Neurology Tags: Corrections Source Type: research